1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Cell Line Development Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Cell Line Development Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Cell Line Development Market Regional Analysis
6.2 North America Cell Line Development Market Revenue 2017-2027 (US$ Million)
6.3 North America Cell Line Development Market Forecast Analysis
7. North America Cell Line Development Market Analysis – by Type
7.1 Primary Cell Line
- 7.1.1 Overview
- 7.1.2 Primary Cell Line: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Hybridomas
- 7.2.1 Overview
- 7.2.2 Hybridomas: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Continuous Cell Lines
- 7.3.1 Overview
- 7.3.2 Continuous Cell Lines: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Recombinant Cell Line
- 7.4.1 Overview
- 7.4.2 Recombinant Cell Line: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. North America Cell Line Development Market Analysis – by Product
8.1 Equipment
- 8.1.1 Overview
- 8.1.2 Equipment: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Media & Reagent
- 8.2.1 Overview
- 8.2.2 Media & Reagent: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. North America Cell Line Development Market Analysis – by Application
9.1 Drug Discovery
- 9.1.1 Overview
- 9.1.2 Drug Discovery: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.2 Bioproduction
- 9.2.1 Overview
- 9.2.2 Bioproduction: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
9.3 Tissue Engineering
- 9.3.1 Overview
- 9.3.2 Tissue Engineering: North America Cell Line Development Market – Revenue and Forecast, 2017-2027 (US$ Million)
10. North America Cell Line Development Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Cell Line Development Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.2.1.1 North America Cell Line Development Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.1.1 US: North America Cell Line Development Market Breakdown, by Type
- 10.2.1.1.2 US: North America Cell Line Development Market Breakdown, by Product
- 10.2.1.1.3 US: North America Cell Line Development Market Breakdown, by Application
- 10.2.1.2 Canada:
North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.2.1 Canada: North America Cell Line Development Market Breakdown, by Type
- 10.2.1.2.2 Canada: North America Cell Line Development Market Breakdown, by Product
- 10.2.1.2.3 Canada: North America Cell Line Development Market Breakdown, by Application
- 10.2.1.3 Mexico :
North America Cell Line Development Market – Revenue and Forecast to 2027 (US$ Million)
- 10.2.1.3.1 Mexico : North America Cell Line Development Market Breakdown, by Type
- 10.2.1.3.2 Mexico : North America Cell Line Development Market Breakdown, by Product
- 10.2.1.3.3 Mexico : North America Cell Line Development Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Merck KGaA
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Thermo Fisher Scientific, Inc.
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Sartorius AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 SELEXIS
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 BioFactura, Inc.
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 WuXi AppTec
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 LakePharma, Inc.
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 General Electric
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Lonza
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Corning Incorporated
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Get Free Sample For North America Cell Line Development Market
